Call to delay transparency reporting
In a submission to the ACCC, the AMA said doctors need more time to review existing industry commitments and to plan for any ongoing relationships before the ACCC-imposed financial reporting requirements can go ahead.
In edition 18 of the Medicines Australia Code of Conduct, a new reporting regime is proposed that requires reporting of “transfers of value” – such as speaking fees, advisory board fees or sponsorship to attend a conference – subject to the healthcare professional’s consent.
But the ACCC rejected the model, granting only conditional approval of the new code as long as MA agreed to ensure that all relevant transfers made by pharmaceutical member companies to individual healthcare professionals would have to be reported.
To address any privacy issues associated with disclosure, it said MA’s member companies must confirm that a healthcare professional has agreed to have their details reported, or is